O USO DE PSICOESTIMULANTES NA PRÁTICA CLÍNICA: UMA REVISÃO INTEGRATIVA
PDF (Português (Brasil))

Keywords

Metilfenidato
Lisdexanfetamina
Neuroestimulantes
Psicoestimulantes
TDAH

How to Cite

Magalhães Caldeira, E. M., Pereira , A. B. da S., Filho, M. C. M., Durão, L. S., Zottele , D. D. S., Durão , C. S., Angeli, D. S., Tozatto, G. S., Maestri , W. B., Ribeiro , R. S., & Bis, A. M. (2024). O USO DE PSICOESTIMULANTES NA PRÁTICA CLÍNICA: UMA REVISÃO INTEGRATIVA. Brazilian Journal of Implantology and Health Sciences, 6(12), 1638–1650. https://doi.org/10.36557/2674-8169.2024v6n12p1638-1650

Abstract

Este artigo tem por objetivo explorar a literatura médica vigente acerca do uso de psicoestimulantes na prática clínica. Foram utilizadas as bases de dados: PubMed, Scielo, Uptodate, ScienceDirect e Google Acadêmico. Após seleção, os artigos foram submetidos a critérios de inclusão e exclusão para produção de revisão sistemática. Conclui-se que o tratamento sintomático do Transtorno de Déficit de Atenção e Hiperatividade (TDAH) é o principal uso dos neuroestimulantes, sendo o Metilfenidato a primeira linha. Além disso, os neuroestimulantes são a terceira linha no tratamento dos distúrbios centrais de sonolência e a lisdexanfetamina pode ser utilizada no Transtorno de Compulsão Alimentar.

https://doi.org/10.36557/2674-8169.2024v6n12p1638-1650
PDF (Português (Brasil))

References

NEWCORN, J. H. et al. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder. CNS Drugs, v. 31, n. 11, p. 999–1014, 4 out. 2017.

‌2. FARAONE, S. The World Federation of ADHD International Consensus Statement: 208 evidence-based Conclusions about the Disorder. Neuroscience & Biobehavioral Reviews, v. 128, n. 1, p. 789–818, 4 fev. 2021.

‌3. KNECHT, L. et al. Neurociência do TDAH. Brazilian Journal of Implantology and Health Sciences, v. 6, n. 10, p. 3306–3330, 22 out. 2024.

SILVEIRA, F. M. DA; RODRIGUES, F. DE A. INTERFACE CÉREBRO E MÁQUINA: ATIVIDADE NEURONAL NO TRANSTORNO DÉFICIT DE ATENÇÃO E HIPERATIVIDADE. Revista Ibero-Americana de Humanidades, Ciências e Educação, v. 7, n. 10, p. 1764–1776, 31 out. 2021.

QUINTERO, J.; GUTIÉRREZ-CASARES, J. R.; ÁLAMO, C. Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review. Neurology and Therapy, v. 11, n. 4, 11 ago. 2022.

Caye A, Swanson JM, Coghill D, et al. Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol Psychiatry. 2019; 24(3):390-408

CORTESE, S. et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet Psychiatry, v. 5, n. 9, p. 727–738, 7 ago. 2018.

SUN, C.-K. et al. Therapeutic effects of methylphenidate for attention-deficit/hyperactivity disorder in children with borderline intellectual functioning or intellectual disability: A systematic review and meta-analysis. Scientific Reports, v. 9, n. 1, 4 nov. 2019.

LENZI, F. et al. Pharmacotherapy of emotional dysregulation in adults with ADHD: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, v. 84, p. 359–367, jan. 2018.

CHANG, Z. et al. Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study. Biological Psychiatry, v. 80, n. 12, p. 916–922, dez. 2016.

JANGMO, A. et al. Attention-Deficit/Hyperactivity Disorder, School Performance, and Effect of Medication. Journal of the American Academy of Child & Adolescent Psychiatry, v. 58, n. 4, p. 423–432, 1 abr. 2019.

LIANG, S. H.-Y. et al. Suicide risk reduction in youths with attention-deficit/hyperactivity disorder prescribed methylphenidate: A Taiwan nationwide population-based cohort study. Research in Developmental Disabilities, v. 72, p. 96–105, jan. 2018.

BARATEAU, L.; LOPEZ, R.; DAUVILLIERS, Y. Treatment Options for Narcolepsy. CNS Drugs, v. 30, n. 5, p. 369–379, maio 2016.

MONTELEONE, A. M. et al. Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses. Neuroscience & Biobehavioral Reviews, v. 142, n. 142, p. 104857, nov. 2022.

NANDA, A. et al. Adverse Effects of Stimulant Interventions for Attention Deficit Hyperactivity Disorder (ADHD): A Comprehensive Systematic Review. Cureus, v. 15, n. 9, 26 set. 2023.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Eni Maria Magalhães Caldeira, Ana Beatriz da Silva Pereira , Marcos Cézar Menegatti Filho, Lucas Silva Durão, Diogo Durval Stange Zottele , Camila Silva Durão , Deborah Santos Angeli, Gabriel Soares Tozatto, Walter Balarini Maestri , Rebeca Soares Ribeiro , Alex Montovanelli Bis

Downloads

Download data is not yet available.
1 1